Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort study.
Henry AC, van Dongen JC, van Goor IWJM, Smits FJ, Nagelhout A, Besselink MG, Busch OR, Bonsing BA, Bosscha K, van Dam RM, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IH, van der Kolk M, Liem MSL, de Meijer VE, Patijn GA, Roos D, Schreinemakers JM, Wit F, Daamen LA, van Santvoort HC, Molenaar IQ, van Eijck CHJ. Henry AC, et al. Among authors: van goor iwjm. BJS Open. 2023 Mar 7;7(2):zrac174. doi: 10.1093/bjsopen/zrac174. BJS Open. 2023. PMID: 36959099 Free PMC article.
Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
Daamen LA, van Goor IWJM, Schouten TJ, Dorland G, van Roessel SR, Besselink MG, Bonsing BA, Bosscha K, Brosens LAA, Busch OR, van Dam RM, Fariña Sarasqueta A, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IHJT, Intven MPW, Kazemier G, de Meijer VE, Nieuwenhuijs VB, Raicu GM, Roos D, Schreinemakers JMJ, Stommel MWJ, van Velthuysen MF, Verheij J, Verkooijen HM, van Santvoort HC, Molenaar IQ; Dutch Pancreatic Cancer Group. Daamen LA, et al. Among authors: van goor iwjm. Eur J Surg Oncol. 2021 Mar;47(3 Pt B):708-716. doi: 10.1016/j.ejso.2020.11.145. Epub 2020 Dec 2. Eur J Surg Oncol. 2021. PMID: 33323293
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac.
Daamen LA, de Mol van Otterloo SR, van Goor IWJM, Eijkelenkamp H, Erickson BA, Hall WA, Heerkens HD, Meijer GJ, Molenaar IQ, van Santvoort HC, Verkooijen HM, Intven MPW. Daamen LA, et al. Among authors: van goor iwjm. Acta Oncol. 2022 Jan;61(1):111-115. doi: 10.1080/0284186X.2021.2012593. Epub 2021 Dec 8. Acta Oncol. 2022. PMID: 34879792
Alternative Randomized Trial Designs in Surgery: A Systematic Review.
Augustinus S, van Goor IWJM, Berkhof J, Daamen LA, Groot Koerkamp B, Mackay TM, Molenaar IQ, van Santvoort HC, Verkooijen HM, van de Ven PM, Besselink MG. Augustinus S, et al. Among authors: van goor iwjm. Ann Surg. 2022 Nov 1;276(5):753-760. doi: 10.1097/SLA.0000000000005620. Epub 2022 Jul 22. Ann Surg. 2022. PMID: 35866665 Free PMC article.
A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).
van Goor IWJM, Daamen LA, Besselink MG, Bruynzeel AME, Busch OR, Cirkel GA, Groot Koerkamp B, Haj Mohammed N, Heerkens HD, van Laarhoven HWM, Meijer GJ, Nuyttens J, van Santvoort HC, van Tienhoven G, Verkooijen HM, Wilmink JW, Molenaar IQ, Intven MPW; Dutch Pancreatic Cancer Group. van Goor IWJM, et al. Trials. 2022 Oct 28;23(1):913. doi: 10.1186/s13063-022-06829-1. Trials. 2022. PMID: 36307892 Free PMC article. Clinical Trial.
Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).
van Goor IWJM, Daamen LA, Besselink MG, Bruynzeel AME, Busch OR, Cirkel GA, Koerkamp BG, Mohammed NH, Heerkens HD, van Laarhoven HWM, Meijer GJ, Nuyttens J, van Santvoort HC, van Tienhoven G, Verkooijen HM, Wilmink JW, Molenaar IQ, Intven MPW; Dutch Pancreatic Cancer Group. van Goor IWJM, et al. Trials. 2023 Jan 24;24(1):55. doi: 10.1186/s13063-022-07036-8. Trials. 2023. PMID: 36694252 Free PMC article. No abstract available.
Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classification.
van Oosten AF, Daamen LA, Groot VP, Biesma NC, Habib JR, van Goor IWJM, Kinny-Köster B, Burkhart RA, Wolfgang CL, van Santvoort HC, He J, Molenaar IQ. van Oosten AF, et al. Among authors: van goor iwjm. Eur J Surg Oncol. 2023 Sep;49(9):106910. doi: 10.1016/j.ejso.2023.04.009. Epub 2023 Apr 29. Eur J Surg Oncol. 2023. PMID: 37173152 Free article.
Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study.
van Goor IWJM, Schouten TJ, Verburg DN, Besselink MG, Bonsing BA, Bosscha K, Brosens LAA, Busch OR, Cirkel GA, van Dam RM, Festen S, Koerkamp BG, van der Harst E, de Hingh IHJT, Intven MPW, Kazemier G, Los M, Meijer GJ, de Meijer VE, Nieuwenhuijs VB, Roos D, Schreinemakers JMJ, Stommel MWJ, Verdonk RC, van Santvoort HC, Daamen LA, Molenaar IQ; Dutch Pancreatic Cancer Group. van Goor IWJM, et al. Ann Surg. 2024 Jan 1;279(1):132-137. doi: 10.1097/SLA.0000000000006004. Epub 2023 Jul 17. Ann Surg. 2024. PMID: 37450706 Free PMC article.
The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis.
Schouten TJ, van Goor IWJM, Dorland GA, Besselink MG, Bonsing BA, Bosscha K, Brosens LAA, Busch OR, Cirkel GA, van Dam RM, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IHJT, Intven MPW, Kazemier G, Liem MSL, van Lienden KP, Los M, de Meijer VE, Patijn GA, Schreinemakers JMJ, Stommel MWJ, van Tienhoven GJ, Verdonk RC, Verkooijen HM, van Santvoort HC, Molenaar IQ, Daamen LA; Dutch Pancreatic Cancer Group. Schouten TJ, et al. Among authors: van goor iwjm. Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-15070-w. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38386198